The Downsides of Cognitive Enhancement.

Lorenza S Colzato, Bernhard Hommel, Christian Beste
Author Information
  1. Lorenza S Colzato: Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.
  2. Bernhard Hommel: Cognitive Psychology, Faculty of Psychology, Shandong Normal University, Jinan, China. ORCID
  3. Christian Beste: Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany.

Abstract

Cognitive enhancement is becoming progressively popular as a subject of scientific investigation and by the public, although possible adverse effects are not sufficiently understood. We call for cognitive enhancement to build on more specific, mechanistic theories given that a-theoretical approaches to cognitive enhancement are both a cause and a consequence of a strong, if not exclusive focus on the benefits of procedures suited to enhance human cognition. We focus on downsides of cognitive enhancement and suggest that every attempt to enhance human cognition needs to deal with two basic principles: the neuro-competition principle and the nonlinearity principle. We discuss the possibility of both principles in light of recent attempts to improve human cognition by means of transcranial direct current stimulation, a well-established brain stimulation method, and clinically relevant nootropic drugs. We propose that much stronger emphasis on mechanistic theorizing is necessary in guiding future research on both the upsides and the downsides of cognitive enhancement.

Keywords

References

  1. Proc Natl Acad Sci U S A. 2003 May 13;100(10):6186-91 [PMID: 12716966]
  2. Neuron. 2000 Jul;27(1):15-21 [PMID: 10939327]
  3. Exp Brain Res. 2008 Jul;189(1):121-8 [PMID: 18563400]
  4. Trends Neurosci. 2010 Jan;33(1):10-6 [PMID: 19819033]
  5. Behav Brain Sci. 2019 Nov 28;42:e222 [PMID: 31775948]
  6. Environ Res. 1995 Jul;70(1):1-6 [PMID: 8603652]
  7. Trends Cogn Sci. 2007 Mar;11(3):118-25 [PMID: 17276130]
  8. J Neurosci. 2015 Jul 29;35(30):10675-84 [PMID: 26224853]
  9. Curr Biol. 2000 Sep 7;10(17):1079-81 [PMID: 10996079]
  10. Trends Cogn Sci. 2015 Jul;19(7):394-405 [PMID: 26051384]
  11. Trends Neurosci. 2014 Dec;37(12):742-53 [PMID: 25189102]
  12. Trends Cogn Sci. 2015 Jan;19(1):46-54 [PMID: 25487706]
  13. Cognition. 2010 Jun;115(3):458-65 [PMID: 20334856]
  14. J Cogn Neurosci. 2017 Apr;29(4):652-663 [PMID: 27779907]
  15. Psychoneuroendocrinology. 2005 Sep;30(8):771-84 [PMID: 15919583]
  16. Front Hum Neurosci. 2013 Sep 24;7:602 [PMID: 24068995]
  17. AJOB Neurosci. 2019 Jan-Mar;10(1):51-53 [PMID: 31070563]
  18. J Neurophysiol. 2005 Jul;94(1):688-98 [PMID: 15758048]
  19. Int J Neuropsychopharmacol. 2020 Mar 10;23(1):12-19 [PMID: 31701133]
  20. Hum Brain Mapp. 2018 Dec;39(12):5050-5061 [PMID: 30133058]
  21. Behav Brain Sci. 2013 Dec;36(6):661-79 [PMID: 24304775]
  22. Nat Neurosci. 2001 Sep;4(9):953-7 [PMID: 11528429]
  23. Brain. 1983 Sep;106 (Pt 3):643-53 [PMID: 6640274]
  24. Science. 1990 Aug 24;249(4971):892-5 [PMID: 2392679]
  25. Neuroimage. 2014 Jan 15;85 Pt 3:1058-68 [PMID: 23880500]
  26. Curr Biol. 2012 Feb 21;22(4):R108-11 [PMID: 22361141]
  27. J Sleep Res. 1997 Jun;6(2):84-91 [PMID: 9377538]
  28. Neuropharmacology. 2013 Jan;64:496-505 [PMID: 22884611]
  29. Front Hum Neurosci. 2012 Nov 26;6:319 [PMID: 23189050]
  30. Aviat Space Environ Med. 1999 May;70(5):493-8 [PMID: 10332946]
  31. J Cogn Neurosci. 2010 Jun;22(6):1158-64 [PMID: 19413472]
  32. Annu Rev Psychol. 2013;64:135-68 [PMID: 23020641]
  33. Psychol Rev. 1999 Jul;106(3):529-50 [PMID: 10467897]
  34. Eur Neuropsychopharmacol. 2020 Jun;35:89-99 [PMID: 32402650]
  35. Psychopharmacology (Berl). 1984;84(2):158-62 [PMID: 6438674]
  36. Biol Psychiatry. 2011 Jun 15;69(12):e113-25 [PMID: 21531388]
  37. Front Syst Neurosci. 2014 Feb 24;8:25 [PMID: 24605090]
  38. Psychopharmacology (Berl). 2009 Jan;202(1-3):541-7 [PMID: 19011838]
  39. J Psychopharmacol. 2019 Jun;33(6):678-687 [PMID: 30816793]
  40. Philos Trans R Soc Lond B Biol Sci. 2007 Sep 29;362(1485):1585-99 [PMID: 17428779]
  41. J Neurosci. 2016 Jan 20;36(3):938-56 [PMID: 26791222]
  42. Int J Neuropsychopharmacol. 2018 Oct 1;21(10):901-909 [PMID: 30016467]
  43. Trends Cogn Sci. 2011 Jan;15(1):28-36 [PMID: 21146447]
  44. Wiley Interdiscip Rev Cogn Sci. 2014 Sep;5(5):533-549 [PMID: 26308743]
  45. Psychol Sci Public Interest. 2004 Jul;5(1):1-31 [PMID: 26158992]
  46. Sci Eng Ethics. 2009 Sep;15(3):311-41 [PMID: 19543814]
  47. Curr Dir Psychol Sci. 2010 Feb 1;19(1):51-57 [PMID: 20445769]
  48. Hum Psychopharmacol. 2004 Jul;19(5):323-32 [PMID: 15252824]
  49. Hum Psychopharmacol. 2008 Dec;23(8):681-92 [PMID: 19039821]
  50. Psychol Res. 2012 Sep;76(5):634-40 [PMID: 21695470]
  51. Trends Cogn Sci. 2018 Sep;22(9):747-751 [PMID: 30017252]
  52. Curr Opin Neurobiol. 2010 Apr;20(2):199-204 [PMID: 20167474]
  53. J Psychopharmacol. 2011 Feb;25(2):197-204 [PMID: 20212064]
  54. Brain Struct Funct. 2019 Apr;224(3):1291-1300 [PMID: 30701308]
  55. Trends Cogn Sci. 2005 Jan;9(1):34-40 [PMID: 15639439]
  56. J Physiol. 2000 Sep 15;527 Pt 3:633-9 [PMID: 10990547]
  57. Front Psychol. 2016 Jun 17;7:907 [PMID: 27378996]
  58. J Cogn Enhanc. 2019;3(4):388-395 [PMID: 32190812]
  59. Neuropsychologia. 2014 Sep;62:403-23 [PMID: 25068705]
  60. Front Psychiatry. 2018 May 22;9:201 [PMID: 29910746]
  61. Neurosci Biobehav Rev. 2017 Oct;81(Pt A):43-58 [PMID: 28088534]
  62. PLoS One. 2011;6(9):e24140 [PMID: 21909415]
  63. J Math Psychol. 2009 Jun;53(3):180-193 [PMID: 20161328]
  64. Psychol Sci. 2017 Sep;28(9):1228-1239 [PMID: 28703638]
  65. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12788-93 [PMID: 22807481]
  66. Annu Rev Neurosci. 2005;28:403-50 [PMID: 16022602]
  67. J Neurosci. 2014 Dec 10;34(50):16605-10 [PMID: 25505313]
  68. J Neurophysiol. 2019 May 1;121(5):1633-1643 [PMID: 30811254]
  69. Child Youth Serv Rev. 2016 Aug;67:95-104 [PMID: 28529397]
  70. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Aug;4(8):743-750 [PMID: 31103546]
  71. Neurobiol Aging. 2015 Aug;36(8):2348-59 [PMID: 26022770]
  72. Br J Sports Med. 2014 Jun;48(12):973-9 [PMID: 23467962]
  73. Gerontologist. 1997 Aug;37(4):433-40 [PMID: 9279031]
  74. J Neurosci. 2013 Mar 6;33(10):4482-6 [PMID: 23467363]

MeSH Term

Brain
Cognition
Humans
Transcranial Direct Current Stimulation

Word Cloud

Created with Highcharts 10.0.0enhancementcognitivehumancognitionCognitivemechanisticfocusenhancedownsidesprinciplestimulationdrugsbecomingprogressivelypopularsubjectscientificinvestigationpublicalthoughpossibleadverseeffectssufficientlyunderstoodcallbuildspecifictheoriesgivena-theoreticalapproachescauseconsequencestrongexclusivebenefitsproceduressuitedsuggesteveryattemptneedsdealtwobasicprinciples:neuro-competitionnonlinearitydiscusspossibilityprincipleslightrecentattemptsimprovemeanstranscranialdirectcurrentwell-establishedbrainmethodclinicallyrelevantnootropicproposemuchstrongeremphasistheorizingnecessaryguidingfutureresearchupsidesDownsidesEnhancementneuralcompetitionneurotransmitterstDCS

Similar Articles

Cited By